Concepedia

Rune Viig Overgaard

RV

26

Publications

1.3K

Citations

21

H-Index

2005

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Technical University of Denmark

Uppsala University

University of Copenhagen

Ferring Pharmaceuticals (Denmark)

Rune Viig Overgaard is an author at Novo Nordisk (Denmark) specializing in engineering, medicine, and stochastic differential equations.

ORCID

Top concepts

Publications per year

2005–2023

26

Publications

26

Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians

Jonas Bech Møller, Maria Pedersen, Haruhiko Tanaka et al. · Diabetes Care · 2013 · 144 citations · Full text

, , +18

Ethnic Differences in Insulin Sensitivity, β-Cell Function, and Hepatic Extraction Between Japanese and Caucasians: A Minimal Model Analysis

Jonas Bech Møller, Chiara Dalla Man, Rune Viig Overgaard et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 100 citations · Full text

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials

Rune Viig Overgaard, Andrea Navarria, Steen H. Ingwersen et al. · Clinical Pharmacokinetics · 2021 · 100 citations · Full text

Exposure–response analyses of liraglutide 3.0 mg for weight management

John Wilding, Rune Viig Overgaard, Lisbeth V. Jacobsen et al. · Diabetes Obesity and Metabolism · 2016 · 97 citations · Full text

Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes

Rune Viig Overgaard, CHRISTIN L. HERTZ, Steen H. Ingwersen et al. · Cell Reports Medicine · 2021 · 94 citations · Full text

Rows per page

1–5 of 26